kallidin, des-arg(10)- has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
Bhoola, KD; Borquez, C; Ehrenfeld, P; Figueroa, CD; Lizama, A; Manso, L; Matus, CE; Naran, A; Pavicic, MF; Poblete, MT; Sarmiento, J | 1 |
2 other study(ies) available for kallidin, des-arg(10)- and Breast Cancer
Article | Year |
---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
Topics: Bradykinin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Kallidin; Kallikreins; Kininogens; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Neoplasm Invasiveness; Receptor, Bradykinin B1; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Tissue Kallikreins; Up-Regulation | 2014 |